News|Articles|July 6, 2026
4 Gastroenterology Headlines You Missed in June 2026
Author(s)Abigail Brooks, MA
Fact checked by: Victoria Johnson
Catch up on phase 3 data for tulisokibart and obefazimod, expert perspective on linaclotide's expanded FDA approval, and more.
Advertisement
Advertisement
June brought continued momentum in
Advertisement
Advertisement
